Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The environment and disease: association or causation?
mfERG_LAB: Software for processing multifocal electroretinography signals.
Infectious causes of multiple sclerosis.
CD4 cell response to interval therapy with natalizumab.
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.
An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β.
[Multiple sclerosis: new approaches to comprehensive treatment and rehabilitation using the method of reflexology].
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
Multiple sclerosis treatment: current best practice.
On dihydroorotate dehydrogenases, their inhibitors and uses.
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination.
Minocycline treatment for rheumatoid arthritis: an open dose finding study.
The King-Devick (K-D) test of rapid eye movements: A bedside correlate of disability and quality of life in MS.
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
Acute disseminated encephalomyelitis in children: a single institution experience of 28 patients.
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey.
European medicines agency's committee for medicinal products for human use issues positive opinion on marketing authorisation application for Fampyra
Disease-modifying drugs for multiple sclerosis and JC virus expression.

Pages